IHS Chemical Week

World News and Views :: Top of the News

BASF to acquire US enzyme biotechnology company Verenium

4:50 AM MDT | September 20, 2013 | Deepti Ramesh

BASF says that its BASF Corp. subsidiary has entered into an agreement to begin a cash tender offer for all the outstanding shares of common stock of industrial biotechnology company Verenium (San Diego), for $4/share. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be about $62 million, BASF says. Verenium, which is focused on the development and commercialization of high-performance enzymes, recorded sales of $57 million in 2012. The offer corresponds to a premium of 56% above the volume-weighted average...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa